Most people who get high-risk HPV never develop cancer

Between 80 and 90 percent of people infected with high-risk HPV clear the virus on their own within one to two years. Your immune system recognizes it as a threat and eliminates it without treatment. This is the most common outcome, and it happens without symptoms or intervention.

For the small percentage whose bodies do not clear the virus, the risk of cancer depends on which type of high-risk HPV you have, how long the infection persists, and whether screening catches any changes early. The progression from persistent infection to cancer typically takes years—often a decade or more—which is why regular screening is so effective at stopping cancer before it starts.

Key Takeaways

  • About 80 to 90 percent of high-risk HPV infections clear on their own within one to two years without causing cancer.
  • Persistent infection with high-risk HPV increases cancer risk, but most people with persistent infection still never develop cancer.
  • HPV 16 and HPV 18 carry higher cancer risk than other high-risk types, and they account for most HPV-related cancers.
  • Regular screening (Pap tests, HPV tests, or both) catches precancerous changes before they become cancer, making prevention possible.
  • The time from persistent HPV infection to cancer usually spans many years, giving screening time to work.

What happens when your body does not clear high-risk HPV

When high-risk HPV persists in your body—meaning the infection lasts longer than two years—the virus can cause cells in the cervix, anus, throat, or other areas to change. These changes are not cancer yet. They are called precancerous lesions or dysplasia, and they can be detected and removed before they ever become cancer.

The exact percentage of people with persistent high-risk HPV who eventually develop cancer varies widely depending on the HPV type and whether screening catches changes early. Without screening, studies show that persistent infection with HPV 16 or HPV 18 carries a higher risk than other high-risk types. But even with persistent infection, most people still do not develop cancer—especially if changes are found and treated during screening.

HPV 16 and HPV 18 carry the highest cancer risk

HPV 16 and HPV 18 are responsible for roughly 70 percent of all cervical cancers and most HPV-related cancers of the anus, throat, and other sites. These two types are considered higher-risk than the other high-risk HPV strains. If you have persistent infection with HPV 16 or HPV 18, your risk of developing precancerous changes is higher than with other high-risk types.

However, "higher risk" does not mean "certain." Studies of women with persistent HPV 16 infection show that without any screening or treatment, roughly 30 percent develop cervical cancer over 30 years. That means 70 percent do not, even without intervention. With regular screening, the risk drops dramatically because precancerous changes are caught and removed long before cancer develops.

How screening prevents cancer from developing

Screening works by finding precancerous changes before they become invasive cancer. A Pap test looks for these changes directly. An HPV test looks for the virus itself. Both can detect problems years before cancer would develop, giving you and your doctor time to monitor the changes or remove them.

If screening finds precancerous cells, your doctor can remove them through procedures like a loop electrosurgical excision procedure (LEEP) or a cone biopsy. Removing precancerous tissue stops the progression to cancer. This is why people with regular screening have much lower rates of cervical cancer than people without screening—not because screening prevents HPV infection, but because it stops the virus from progressing to cancer.

Timeline from infection to cancer

High-risk HPV does not turn into cancer overnight. The typical timeline is measured in years. Most people clear the virus within one to two years. For those with persistent infection, precancerous changes usually appear within three to five years, though this varies. The progression from precancerous changes to invasive cancer can take another five to ten years or longer.

This slow progression is why screening every three to five years (depending on your age and screening method) is effective. The time between screening visits is usually short enough to catch changes before they become cancer. If you have had regular screening your entire adult life, your risk of cervical cancer is very low, even if you have had high-risk HPV.

What increases your risk if you have persistent HPV

Several factors make it more likely that persistent high-risk HPV will progress to cancer. Smoking weakens your immune system's ability to clear the virus. A weakened immune system from HIV, immunosuppressive medications, or other causes also increases risk. Infection with multiple high-risk HPV types at once raises the likelihood of progression compared to a single type.

Age at infection matters too. People infected with high-risk HPV in their teens or twenties have more time for the virus to persist and progress, compared to people infected later in life. However, even with these risk factors, most people with persistent infection still do not develop cancer, especially if they are screened regularly.

HPV-related cancers beyond the cervix

High-risk HPV can cause cancer of the anus, throat (oropharynx), vulva, vagina, and penis, though cervical cancer is the most common. The progression timeline and cancer risk for these sites are less well-studied than for cervical cancer, partly because screening for these cancers is not routine the way cervical screening is. For throat and anal cancers, the progression from persistent infection to cancer can take many years, similar to cervical cancer.

Screening for non-cervical HPV-related cancers is not standard practice for most people, which means these cancers are often found at a later stage. This is one reason why HPV vaccination, which prevents infection with high-risk types before exposure, is recommended for people up to age 45 in some cases and age 26 in most cases.

Frequently Asked Questions

If I test positive for high-risk HPV, will I definitely get cancer?

No. Most people who test positive for high-risk HPV clear the virus on their own and never develop cancer. Even if the infection persists, most people still do not develop cancer, especially with regular screening. A positive HPV test means you need follow-up screening, not that cancer is inevitable.

How often should I be screened if I have high-risk HPV?

Screening frequency depends on your age, your previous test results, and your doctor's recommendations. If you test positive for high-risk HPV, your doctor will likely recommend more frequent screening or a colposcopy (a closer look at the cervix) to check for precancerous changes. Do not skip these follow-up visits—they are how cancer is prevented.

Can high-risk HPV come back after my body clears it?

Yes, you can be infected with high-risk HPV again after clearing a previous infection. This is why screening remains important throughout your life. However, if you were vaccinated against HPV before your first infection, you have protection against the types in the vaccine and are less likely to be reinfected with those specific types.

Does a high-risk HPV diagnosis mean I have cancer right now?

No. An HPV diagnosis means you have the virus, not cancer. Cancer develops only if the virus persists and causes precancerous changes that are not caught and removed by screening. Most people with high-risk HPV never develop cancer at any point in their lives.

What should I do if I test positive for high-risk HPV?

Follow your doctor's recommendations for follow-up screening or colposcopy. Attend all scheduled appointments. Do not smoke, as smoking weakens your immune system's ability to clear the virus. Ask your doctor about any steps you can take to support your immune system. Most people with high-risk HPV who follow screening recommendations never develop cancer.